Darlene Petersen, MD and Paula Cook, MD
Darlene Petersen, MD and Paula Cook, MD
Highlights from CSAM 2023
Highlights from CSAM 2023
Highlights from CSAM 2023
Tuesday 19th September 2023
Catch the latest insights from CSAM 2023 on dopamine's impact, fentanyl trends, adolescent addiction, stimulants, cannabis use disorder, and harm reduction.
Explicit
42 minutes
Informative
Empowering
Inspiring
Compassionate
Educational
About this podcast
Author:
Darlene Petersen, MD and Paula Cook, MD
Overview:
Categories:
Understanding Addiction & Recovery
Navigating Alcohol Dependency
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Family Recovery from Addiction
Links:
Visit site
Episodes:
98 (View all)
Do you want to link to this podcast?
Get the buttons here!CSAM 2023: Fresh Perspectives on Addiction Treatment and Trends
Episode Overview
- Insights into dopamine's impact on the pleasure-pain balance and neuroadaptation
- Emerging trends in fentanyl, stimulants, cannabis use, and alcohol
- Challenges and strategies for benzodiazepine protocols for alcohol withdrawal
- Principles of harm reduction and its importance in addiction medicine
Harm reduction is any strategy that reduces the harm of risky behaviors, including the use of alcohol and drugs without necessarily having the requirement of quitting those behaviors. It focuses on safety first, doesn't judge people's choice to use alcohol or drugs, and is based on radical acceptance.
Fresh from the California Society of Addiction Medicine's Annual Conference, Dr. Darlene Petersen and Dr. Paula Cook unpack the key takeaways from CSAM 2023. This episode of 'The Addiction Files' dives into the latest research and discussions that are shaping the future of addiction medicine. Ever wondered how our dopamine-driven world impacts mental health? Dr.
Anna Lemke's riveting keynote on dopamine overstimulation explores this, shedding light on the delicate balance between pleasure and pain and how our modern habits are rewiring our brains. She suggests that stepping back from dopamine-heavy activities and embracing discomfort might just be the key to resetting our happiness levels. The episode doesn't stop there. It covers a wide range of topics including the troubling rise of fentanyl use, adolescent addiction challenges, and the complexities of stimulant abuse, particularly methamphetamine. Dr.
Javier Ballester's insights on off-label treatments for stimulants provide new avenues for addressing this growing issue. Cannabis use disorder also takes center stage, with Dr. Alexander Young discussing the alarming rates of withdrawal symptoms and their links to acute psychosis and schizophrenia. For those dealing with alcohol use disorder, Dr. Barbara Mason highlights the underutilization of FDA-approved medications and stresses the importance of treatment accessibility beyond specialist settings. Benzodiazepine protocols for alcohol withdrawal, discussed by Dr. Christopher Blazes and Dr.
Elizabeth Howell, bring attention to the difficulties in managing these medications both inpatient and outpatient. The conference's panel on harm reduction shifts the narrative from moral judgment to health-focused solutions, advocating for radical acceptance and person-first language. By understanding the reasons behind drug use, this approach aims to reduce harm and support recovery more effectively. Whether you're a medical professional or someone interested in the latest in addiction treatment, this episode offers a wealth of knowledge and practical insights.